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Abstract: INTRODUCTION This retrospective study investigates brain malformations and their impact
on neurodevelopmental outcome in children after prenatal surgery for spina bifida (SB). METHODS
Sixty-one patients were included. On neonatal MRI, SB-associated brain malformations were assessed.
Ventricular size, ventriculo-peritoneal shunt (VPS), and endoscopic third ventriculostomy (ETV) were
also documented. Neurodevelopment was assessed with the Bayley-III and correlated with brain malfor-
mations, ventricular size, and VPS/ETV placement. RESULTS Chiari II malformation was detected in
all patients. Corpus callosum (CC) abnormality was noted in 40%, heterotopies in 35%, and cerebellar
parenchymal defects in 11%. 96% had ventriculomegaly; in 46%, VPS/ETV was performed. Cognitive
and language testing yielded results in the low-average range (Bayley-III: Cognitive Composite Score
93.6, Language Composite Score 89.7), motor testing was below average (Motor Composite Score 77.4).
CC abnormalities, heterotopies, and cerebellar defects were not associated with poorer Bayley-III scores,
whereas patients with severe ventriculomegaly performed poorer in all subtests, significantly so for the
language composite score. Patients requiring intervention for hydrocephalus had significantly lower scores
in motor testing. DISCUSSION/CONCLUSION Additional brain malformations in open SB do not seem
to have an impact on cognitive function at 2 years of age. Severe ventriculomegaly is a risk factor for
poorer cognitive outcome; hydrocephalus surgery adds an additional risk for delayed motor function.
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Abstract
Introduction: This retrospective study investigates brain 
malformations and their impact on neurodevelopmental 
outcome in children after prenatal surgery for spina bifida 
(SB). Methods: Sixty-one patients were included. On neona-
tal MRI, SB-associated brain malformations were assessed. 
Ventricular size, ventriculo-peritoneal shunt (VPS), and en-
doscopic third ventriculostomy (ETV) were also document-
ed. Neurodevelopment was assessed with the Bayley-III and 
correlated with brain malformations, ventricular size, and 
VPS/ETV placement. Results: Chiari II malformation was de-
tected in all patients. Corpus callosum (CC) abnormality was 
noted in 40%, heterotopies in 35%, and cerebellar parenchy-
mal defects in 11%. 96% had ventriculomegaly; in 46%, VPS/
ETV was performed. Cognitive and language testing yielded 
results in the low-average range (Bayley-III: Cognitive Com-
posite Score 93.6, Language Composite Score 89.7), motor 
testing was below average (Motor Composite Score 77.4). CC 
abnormalities, heterotopies, and cerebellar defects were not 
associated with poorer Bayley-III scores, whereas patients 
with severe ventriculomegaly performed poorer in all sub-
tests, significantly so for the language composite score. Pa-
tients requiring intervention for hydrocephalus had signifi-
cantly lower scores in motor testing. Discussion/Conclu-
sion: Additional brain malformations in open SB do not 
seem to have an impact on cognitive function at 2 years of 
age. Severe ventriculomegaly is a risk factor for poorer cog-
nitive outcome; hydrocephalus surgery adds an additional 
risk for delayed motor function. © 2021 The Author(s)
Published by S. Karger AG, Basel
Introduction
Open spina bifida (SB), which includes myelomenin-
gocele and myeloschisis, has an incidence of 3.4 per 
10,000 live births and is one of the most common and 
devastating congenital anomalies of the central nervous 
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system [1]. Failure of primary neurulation leads to open 
exposure of the neural placode through a defect in the 
vertebral column and overlying soft tissues. The severity 
of the various neurologic dysfunctions (cerebral, spinal, 
and peripheral) is correlated with level and extent of the 
spinal defect and with a cluster of cerebral anomalies 
known as Chiari II malformation (CM II) [1–4]. CM II is 
detected in 44–100% of patients with SB [5–7]. It includes 
hindbrain herniation (HH), brain stem abnormalities, 
and a small, crowded posterior fossa and is associated 
with additional malformations of the fore, mid-, and 
hindbrain [1, 8]. Typically, these include structural anom-
alies of the corpus callosum (CC), disorders of cortical 
development, especially periventricular heterotypies and 
cerebellar defects. Taken together, CM II was therefore 
classified as a pancerebral malformation [8–10].
One important consequence of CM II is ventriculo-
megaly, an almost constant finding in fetal and newborn 
ultrasound and/or MRI. Hydrocephalus, the correlating 
clinical entity of ventriculomegaly, afflicts about 90% of 
patients with open SB and requires CSF diversion in near-
ly all patients [1, 9]. Notably, the need for CSF diversion 
in patients who underwent fetal SB repair was markedly 
reduced [1]. In our cohort, the shunt rate was 37% [11]. 
Outcomes of patients with fetal ventriculomegaly are well 
documented. In SB patients with hydrocephalus, cogni-
tive impairment is more severe than in patients without 
hydrocephalus, with particularly poor performance in ex-
ecutive functions [12].
The theory generally consented to today regarding the 
disastrous and irreversible neurological deficit associated 
with SB is the “2-hit-hypothesis” formulated by Heffez et al. 
[13], Hutchins et al. [14], and Meuli et al. [15] in the mid-
nineties, according to which the secondary, in utero ac-
quired, damage (=second, “extrinsic,” hit) to the patholog-
ically exposed spinal cord tissue seems to be a more impor-
tant pathogenic factor than the failure of neural tube closure 
(first, “intrinsic,” hit) itself. Novel fetal sheep models, cre-
ated by Meuli et al. [16, 17], and evidence from aborted hu-
man fetuses with open SB [14, 15] strongly support the 
pathogenetic view of progressive neural tissue destruction 
and loss of function with ongoing gestation and are also 
compellingly indicative that timely in utero SB coverage 
spares function at birth [18]. Importantly, in a mouse mod-
el of a naturally occurring open SB, findings were perfectly 
consistent with the 2-hit-pathogenesis [19, 20].
The above mentioned evidence leads to the first open 
human prenatal myelomeningocele repair performed in 
Philadelphia by Adzick et al. [21] in the year 1997. Sub-
sequent studies showed largely reversible HH after pre-
natal SB repair and a markedly reduced shunt rate and 
improved mobility compared with postnatal repair [1, 
22–24]. In 2011, the MOMS trial compared prenatal SB 
repair with the standard postnatal repair and showed 
that prenatal intervention significantly improved out-
comes in various domains, but was not free of maternal 
and fetal risks [1]. Yet, the trial was stopped for higher 
efficacy of prenatal over postnatal surgery [1]. Thus, pre-
natal surgery has become a standard treatment option for 
selected patients. In 2010, the Zurich Center for Fetal Di-
agnosis and Therapy (www.swissfetus.ch) started a fetal 
surgery program [25]. To date, the center has performed 
over 150 open fetal MMC repairs [11]. Our outcome re-
sults are comparable or partly even better when com-
pared to MOMS [26]. The main goal of the present study 
was to identify SB-associated brain malformations in a 
cohort of consecutive SB patients undergoing fetal sur-
gery, particularly focusing on CC abnormalities, heter-
otopies, additional cerebellar defects beside the classical 
CM II, as well as to look at ventriculomegaly and to de-
termine whether these pathologies have a negative im-
pact on cognitive, language, and motor development in 
early life.
Patients and Methods
Between December 2010 and July 2017, 61 consecutive patients 
underwent open prenatal SB repair at the Zurich Center for Fetal 
Diagnosis and Therapy (www.swissfetus.ch), Switzerland. The 
MOMS inclusion and exclusion criteria were applied with some 
modifications (the criteria maternal BMI, hypertension, psychoso-
cial background as well as certain fetal anomalies such as irrelevant 
kidney anomalies and minor genetic anomalies were evaluated on 
an individual basis) [1]. This single-center retrospective analysis 
was performed on brain malformations, cognitive, and motor out-
come parameters of patients with SB. Baseline characteristics, sex, 
gestational age at fetal surgery and birth, and birth weight were 
collected in a REDCap database.
All neonates underwent MRI of the neuroaxis using a 1.5 or 3-T 
scanner (Discovery MR450 or MR750, GE Healthcare, Waukesha, 
WI, USA) within the first 14 days of life. None had ventriculo-
peritoneal shunt (VPS) or endoscopic third ventriculostomy 
(ETV) at the time of imaging. Age at VPS and ETV intervention 
was documented.
Cranial MRI findings were analyzed by an experienced pediat-
ric neuroradiologist for CM II, ventricular size, CC abnormalities, 
presence, number, and location of heterotopies, presence and ex-
tent of HH, cerebellar diameter, and presence of cerebellar paren-
chymal defects. CM II was considered present when the following 
criteria were met: downward herniation of the cerebellum, down-
ward displacement of medulla, pons, and fourth ventricle, medul-
lary kinking, abnormally shaped fourth ventricle, hypoplastic ten-
torium, and beaking of the quadrigeminal plate [1, 6, 8, 27]. HH 
was defined as a transforaminal herniation of brainstem and cer-
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ebellum lower than the foramen magnum into the cervical spinal 
canal. Ventricular size was assessed by measurement of the lateral 
ventricular diameter on a coronal slice at the level of the ventricu-
lar atrium. Mild ventriculomegaly was defined as 10.1–15 mm, 
moderate as 15.1–20 mm, moderate-severe 20.1–25 mm, and se-
vere larger than 25 mm [28]. Regarding the FOHR index, ventric-
ulomegaly was defined as a ratio larger than 0.44 [29] (Even 
though, theoretically, a comparison of postnatal with prenatal data 
regarding CC anomalies, heterotypies, and cerebellar defects, 
would be interesting, we have not included such data, since these 
pathologies are usually not yet detectable around midgestation, 
when our imaging was done).
Development was assessed by experienced pediatricians of our 
Child Development Center using the Bayley Scales of Infant and 
Toddler Development (Bayley-III) at the adjusted age of 24 
months. The Bayley-III is used for children from 1 to 42 months 
of age and provides 3 scores: Cognitive Composite Score (CCS), 
Language Composite Score (LCS), and Motor Composite Score 
(MCS). Each score has a mean of 100 and a standard deviation 
(SD) of ±15 [30].
Statistical analyses were performed by the University of Zurich, 
Switzerland. Descriptive statistics included mean and SD for con-
tinuous variables and numbers and percentages of total for cate-
gorical and ordinal variables.
Bayley-III scores were compared between children with and 
without VPS/ETV. The comparison used box plots, t tests, and es-
timation of between-group difference with 95% confidence inter-
vals.
Multiple linear regression models (OLS regression) were used 
to model the association of CC abnormalities, heterotopia binary 
and cerebellar defects on Bayley scores. Bayley scores were mod-
eled with log-transformation in order to fulfill model assumptions. 
Additionally, the variables gestational age and gender were consid-
ered as confounders in the models.
All analyses were carried out with R, version 3.6.0 (April 26, 
2019) (R Core Team (2019). R Markdown was used for dynamic 
reporting. The corresponding reporting guideline for observation-
al studies is STROBE [31].
Results
General
Sixty-one patients were included in the analysis. One 
patient died on the first day of life due to severe lung hy-
poplasia (no follow-up data). Female/male ratio was 3:2. 
In utero, surgery was performed between 22 + 1 and 26 + 
2 gestational weeks, mean 25 + 1. Caesarean section was 
performed between 25 + 2 and 37 + 3 gestational weeks, 
and mean gestational age at birth was 35 + 4 weeks. Pre-
maturity, defined as birth before 37 gestational weeks, oc-
curred in 28 patients (46.6%): from these, 24 patients 
were late preterm (85.7%), 3 children were very preterm 
(10.7%) and 1 girl was born extremely preterm (3.5%; 25 
+ 2 gestational weeks) due to an acute placental abruption 
during MMC repair, mandating emergency delivery. 
Birth weight ranged from 850 to 3,390 g.
Fig. 1. Dysplasia of the lower left cerebellar hemisphere (T2 coro-
nary imaging).
Fig. 2. Dysplastic vermian tissue (arrow is pointed to the dysplastic 
vermis; T2/FIESTA sagittal imaging).
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Neonatal MRI
On the first postnatal cranial MRI, CM II was present 
in all 60 patients (100%). Normal position of the cerebel-
lum was observed in 56 patients (93.3%). HH was de-
tected in 4 patients (6.7%) with displacement ranging 
from C1 to C4 (in 1 patient to C1, in 2 to C2, and in 1 to 
C4). In 36 patients (60%), the CC was completely normal 
while in 24 patients (40%) a CC abnormality could be 
detected: 14 patients had a hypogenesis of the splenium, 
9 patients showed a dysplastic CC, and 1 patient had CC 
agenesis.
Heterotopies were present in 21 patients (35%). In 18 
patients, they were subependymal, in 2 subependymal 
and cerebellar, and 1 patient had a single cerebellar het-
erotopia. The number of subependymal heterotopies 
ranged from 1 to 23, mean 2.1 per patient.
Cerebellar parenchymal defects could be detected in 7 
patients (12%). Illustrative examples are shown in Figures 
1 and 2. Transverse cerebellar diameter (maximum width 
in coronal MRI) ranged from 34 to 66 mm, mean 46.2 
mm.
Neonatal ventricular size ranged from 8.5 to 37.5 mm, 
mean 17.1 mm. Mean FOHR was 0.5, with a range of 
0.41–0.8. Ventriculomegaly, defined as lateral ventricles 
larger than 10 mm, was present in 58 (97%) patients (de-
tails given in Table 1). When using the FOHR Index 51 
(85%), patients had a ventriculomegaly (FOHR >0.44).
Hydrocephalus and CSF Diversion
In 32 patients (53%), a CSF diversion was not neces-
sary within the first 2 years of life. Due to ventriculomeg-
aly and/or clinical signs of increased cerebral pressure, 
surgical intervention was necessary in 28 (47%) patients 
24 received a VPS, 20 within the first year, 4 within the 
second year. Six patients received a primary ETV. 2 pa-
tients of these needed a secondary VPS due to ETV failure 
(Table 1).
Width of the lateral ventricles and FOHR is corre-
lated with VPS and ETV status (Fig. 3). The correlation 
shows that in patients with larger ventricles/larger 
FOHR, VPS/ETV was needed in a higher number of pa-
tients. In more detail, VPS/ETV patients had a mean of 
the lateral ventricles of 20.4 mm and a FOHR of 0.565 
(p < 0.0001). Those who were not shunted had a mean 
of the lateral ventricles of 14.4 mm and a FOHR of 0.485 
(p < 0.0001).
Development
The CCS was available for 55 (90%) patients. Mean 
score was 93.6 (range 55–130, SD 14.3). LCS, tested in the 
same 55 (90%) patients, yielded a mean of 89.7 (range 
45–112, SD 13.1). MCS was assessed in 48 (79%) patients 
with a mean score of 77.4 (range 45–112, SD 13.0).
Additional brain malformations, namely CC abnor-
malities, heterotopies, and cerebellar defects, were not as-
sociated with any of the 3 Bayley Composite Scores. The 
comparison of children with 2 brain malformations to 
those without a malformation also showed no evidence 
Table 1. Imaging results and CSF diversion data
N 60 (100)
CH II (n, %) 60 (100)
HH (n, %) 4 (6.7)
Abnormal CC (n, %) 24 (40)
Heterotopies (n, %) 21 (35)
Cerebellar defects (n, %) 7 (11.66)
Transverse cerebellar diameter, mean mm, range 46.2 (34–66)
Ventricular size, mean mm, range 17.1 (8.5–37.5)
Ventriculomegaly (n, %) 58 (96.66)
Mild 22 (36.66)
Moderate 21 (35)
Moderate severe 9 (15)
Severe 5 (8.33)
n/a 1
VPS/ETV (n, %) 28 (47)
VPS 24 (40)
ETV 6 (10)
ETV failure, secondary VPS 2 (3)
VPS, ventriculo-peritoneal shunt; ETV, endoscopic third ven-
triculostomy; CC, corpus callosum; HH, hindbrain herniation; CH 









































Fig. 3. Associations between lateral ventricular diameter and 
FOHR in patients with and without VPS/ETV (A 0 in the x-axis 
indicates children with neither VPS nor ETV, a 1 indicates chil-
dren with either VPS or ETV or both). VPS, ventriculo-peritoneal 
shunt; ETV, endoscopic third ventriculostomy.
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for a between-group difference in the Bayley scores. In the 
1 infant with all 3 additional malformations, no compar-
ison was possible.
CCS, LCS, and MCS are related to the degree of ven-
triculomegaly (Fig. 4). Shortly, the group of children with 
severe ventriculomegaly had lower scores in all Bayley 
scores; however, only LCS was significant (p < 0.022). In 
children without ventriculomegaly and those with mild, 
moderate, and moderate-severe ventriculomegaly, no 
significant differences in the Bayley-III scores were de-
tected. Confounding factors, as gender and gestational 
age, were adjusted, with no association between ventricu-
lomegaly and Bayley outcomes.
In Figure 5, the association between patients with 
and without VPS/ETV and Bayley outcomes is illustrat-
ed. In brief, regarding CCS and LCS, there is no differ-
ence within the 2 groups (p < 0.094, respectively, 
p < 0.961), whereas for the MCS, children with VPS/
ETV performed significantly worse than children with-
out (p < 0.014).
Discussion
The Zurich Center for Fetal Diagnosis and Therapy 
(www.swissfetus.ch) and the Zurich Center for SB of 
the University Children’s Hospital Zurich jointly rep-
resent one of the largest pediatric centers for SB patients 
worldwide. Due to a consistently high volume of prena-
tal surgery cases (actually 25–30 per year), the cohort of 
postnatal patients with a history of fetal SB repair is 










































































Fig. 4. Associations between Bayley-III 
outcomes and ventriculomegaly.
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prehensive standard long-term follow-up program 
(birth – 18 years of age) with all pertinent data entered 
into a REDCap-based registry. To the best of our knowl-
edge, this is the first study delivering comprehensive 
information on additional brain malformations and 
their impact on early developmental outcome in chil-
dren after fetal SB repair.
Some of our results are novel, in particular the finding 
that additional brain malformations alone (i.e., CC ab-
normalities or heterotopies or cerebellar defects) or taken 
together do not seem to have an impact on any develop-
mental domain when tested at 24 months of age. Other 
findings as severe ventriculomegaly, known to be a strong 
risk factor for poorer cognitive and language outcome, 
are corroborating previously published data [12, 32].
The following aspects deserve an in-depth discus-
sion. Children in our cohort had cognition and lan-
guage development in the low-average range compared 
to the population norm. These results are in line with 
the literature [28, 33, 34]. Reported IQ’s of postnatally 
repaired SB patients are tendentially worse, that is, be-
low the population average or in the low-average range 
with a heterogenous profile [28, 33, 34]. Yet, the MOMS 
trial demonstrated lower cognitive performance also 
for children with prenatally repaired SB at age 30 
months [1]. Similar results could be shown in a review 
by Inversetti [24].
Of note, the current literature claims that primary 
brain malformations in SB patients deserve serious con-
sideration regarding cognitive outcome. Accordingly, we 
closely examined 3 such additional cerebral malforma-
tions which may have had a negative impact on early life 
development. The key finding of this study is that neither 
CC abnormalities, heterotopies nor additional severe cer-
ebellar defects alone or in combination of 2 or 3, had an 
identifiable negative impact.
One other main finding was that severe ventriculo-
megaly had the highest predictive power regarding poor-
er developmental outcomes, although only language per-
formance reached statistical significance. In children with 
a mild, moderate, and moderate-severe ventriculomega-
ly, no significant difference was detectable in all 3 Bayley 
scores compared to the group of children without ven-
triculomegaly. These results are comparable to the study 
by Lindquist, who demonstrated that children after post-
natal surgery for SB without hydrocephalus performed 
better in all neuropsychological domains, with a total IQ 
of 103, compared to an IQ of 75 in SB children with hy-
drocephalus [35]. Interestingly, Houtrow [36] reported 
that children at 30 months of age with nonshunted hydro-
cephalus did not perform worse in neurodevelopmental 
testing than children with shunted hydrocephalus or chil-
dren without hydrocephalus, yet children with severe hy-
drocephalus had lower scores. Our results are in line with 
these findings. Only children with a neonatal ventriculo-
megaly larger than 25 mm had worse Bayley scores. 
MOMS data suggested that larger lateral ventricular size 
at initial prenatal imaging was associated with an in-
creased need for shunting [1]. This seems especially true 
in patients with a fetal ventricular size larger than 15 mm 
[37, 38]. In our cohort, VPS and ETV placement was nec-
essary in patients up to the age of 2 years with a mean 









































































Fig. 5. Associations between Bayley out-
comes and VPS/ETV (A 0 in the x-axis in-
dicates children with neither VPS nor ETV, 
a 1 indicates children with either VPS or 
ETV or both). VPS, ventriculo-peritoneal 
shunt; ETV, endoscopic third ventriculos-
tomy.
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For children with and without VPS/ETV, Bayley test-
ing was different only in the MCS, with a significantly 
lower score in the group of shunted children with severe 
ventriculomegaly. In the CCS and LCS, a significant dif-
ference between the 2 groups was not found, with be-
tween-group estimates in the CCS of 6.5 and in the LCS 
of 0.18. VPS/ETV on its own did not appear to have a 
negative impact on cognition, but on motor function 
when tested at the age of 2 years.
Our study cannot answer the interesting question 
whether the poorer cognitive performance is due to hy-
drocephalus or the structural changes leading to it, or, 
eventually, both. Briefly summarized, our data suggest 
that low-average IQ Bayley scores result from the typical 
primary brain malformations in SB, while the corre-
sponding hydrocephalus adds an additional negative im-
pact, especially if severe.
We have already published that a classical HH was 
present in 90% of fetuses before fetal surgery and that it 
resolved in utero in 90% of these within 4 weeks postop-
eratively [11]. As to be expected, in our postnatal popula-
tion, HH was absent in 93.3% while MOMS reported only 
36% of reversed HHs [1]. We have speculated about pos-
sible explanations for that striking difference (different 
definitions, MRI evaluations, or operative technique), but 
none of these is convincing. For children with cerebellar 
dysplasia/low cerebellar volume, testing of fine motor 
function should be a focus of future investigations. It will 
be interesting to investigate the effect of brain malforma-
tions on cognition when detailed assessment of executive 
functions is included in cognitive testing, for example, at 
5 and 10 years of age. Definitely, our study underscores 
the necessity of prenatal counseling regarding brain mal-
formations and ventriculomegaly and their possible im-
pact on outcomes.
Limitations of our study include that results were not 
compared to SB children after postnatal surgery. Also, 
due to strict eligibility criteria, our cohort harbors a selec-
tion bias (potentially “healthier” patients). In fact, fetuses 
exhibiting, for instance, severe other malformations or 
genetic syndromes, were excluded. Finally, due to the pa-
tient’s young age, we cannot yet present potentially re-
vealing long-term outcome data on more specific cogni-
tive testing (i.e., executive functions and visual percep-
tion).
In summary, this study produces evidence that addi-
tional structural brain malformations, namely CC anom-
alies, heterotopies, and cerebellar defects, identified in 
neonates with a history of fetal surgery for SB, did not 
negatively impact developmental outcomes at 2 years of 
age. We demonstrate further that, in contrast, severe neo-
natal ventriculomegaly is a strong risk factor for poorer 
development. The cohort of patients reported on here will 
be followed in an already designed longitudinal study in 
order to look at specific cognitive skills, especially execu-
tive functions in the years to come.
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